The U.S. Food and Drug Administration (FDA) has lifted the clinical hold on a Phase 1 clinical trial that’s testing AMX0114, ...

Eli Lilly partnership aims to identify new treatments for ALS based on antibodies from people with very slow disease ...

Team Gleason has expanded its collaboration with Stentrode developer Synchron to help teach people about brain-computer ...

The ALS Association will host its second ALS Nexus conference in August, with the goal of making the disease a livable one ...

ALS patients' disease progression and improved functional independence and mobility in a real-world setting, per a study.

Riluzole treatment and a diet containing high glycemic index foods interact 'synergistically' to slow ALS progression, ...

Half of ALS patients experience constipation, which is associated with faster progression and lower survival rates, per a ...

David Husman, a Chicago businessman, donated the money to advance an ALS and a neuroscience center where his wife had been ...

A study in Italy found ALS incidence and onset rose with living near arable crops (cereals, beans, root crops), and with ...

DNL343 and fosigotifator are made to activate the ISR pathway protein eIF2B, but both failed to slow ALS progression in the ...